Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13C-butyrate and Glucose Breath Testing for Mesenteric Ischemia
NCT06022588Completed
- Sponsor
- Erasmus MC
- Start
- Mar 2021
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Randomised, open-label trial (4 arms), sponsored by Erasmus MC. Primary endpoint: Median concentrations of measured 13CO2 at 4 hours. Started Mar 2021; status: completed.
Beyond the preview
Go deeper on NCT06022588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06022588.